In this study, we revealed MSI1 plays an important role in AKT activation and IL-6 secretion in response to chemo-drug in GBM cells, which eventually contributes to a dynamic interaction between proinflammatory circuits, chemoresistance, and tumor recurrence. The gene discussed is AKT1; the disease is glioblastoma.